538 related articles for article (PubMed ID: 31354486)
1. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
[TBL] [Abstract][Full Text] [Related]
2. Targeting Senescent Cells as Therapy for CKD.
Mylonas KJ; Ferenbach DA
Kidney360; 2024 Jan; 5(1):142-151. PubMed ID: 38049936
[TBL] [Abstract][Full Text] [Related]
3. Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence.
Li C; Shen Y; Huang L; Liu C; Wang J
FASEB J; 2021 Jan; 35(1):e21229. PubMed ID: 33368613
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
Richardson M; Richardson DR
Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
[TBL] [Abstract][Full Text] [Related]
5. Potential Clinical Implications of Senotherapies for Cardiovascular Disease.
Suda M; Katsuumi G; Tchkonia T; Kirkland JL; Minamino T
Circ J; 2024 Feb; 88(3):277-284. PubMed ID: 37880106
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence in the aging and diseased kidney.
Valentijn FA; Falke LL; Nguyen TQ; Goldschmeding R
J Cell Commun Signal; 2018 Mar; 12(1):69-82. PubMed ID: 29260442
[TBL] [Abstract][Full Text] [Related]
7. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease.
Schroth J; Thiemermann C; Henson SM
Front Cell Dev Biol; 2020; 8():564461. PubMed ID: 33163486
[TBL] [Abstract][Full Text] [Related]
8. Targeting cellular senescence in metabolic disease.
Palmer AK; Tchkonia T; Kirkland JL
Mol Metab; 2022 Dec; 66():101601. PubMed ID: 36116755
[TBL] [Abstract][Full Text] [Related]
9. Chemical Strategies for the Detection and Elimination of Senescent Cells.
García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
[TBL] [Abstract][Full Text] [Related]
10. Senotherapy for lung diseases.
Barnes PJ
Adv Pharmacol; 2023; 98():249-271. PubMed ID: 37524489
[TBL] [Abstract][Full Text] [Related]
11. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
Xu J; Zhou L; Liu Y
Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
[TBL] [Abstract][Full Text] [Related]
12. Senopathies-Diseases Associated with Cellular Senescence.
Lushchak O; Schosserer M; Grillari J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
[TBL] [Abstract][Full Text] [Related]
13. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials.
Franzin R; Stasi A; Ranieri E; Netti GS; Cantaluppi V; Gesualdo L; Stallone G; Castellano G
Front Pharmacol; 2021; 12():630419. PubMed ID: 33995028
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
[TBL] [Abstract][Full Text] [Related]
15. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
16. The ageing immune system as a potential target of senolytics.
Du PY; Gandhi A; Bawa M; Gromala J
Oxf Open Immunol; 2023; 4(1):iqad004. PubMed ID: 37255929
[TBL] [Abstract][Full Text] [Related]
17. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
18. Cellular Senescence: A Translational Perspective.
Kirkland JL; Tchkonia T
EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
[TBL] [Abstract][Full Text] [Related]
19. Identification of resibufogenin, a component of toad venom, as a novel senolytic compound in vitro and for potential skin rejuvenation in male mice.
Takaya K; Asou T; Kishi K
Biogerontology; 2023 Dec; 24(6):889-900. PubMed ID: 37395866
[TBL] [Abstract][Full Text] [Related]
20. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
